A carregar...
Repurposing Sigma-1 Receptor Ligands for COVID-19 Therapy?
Outbreaks of emerging infections, such as COVID-19 pandemic especially, confront health professionals with the unique challenge of treating patients. With no time to discover new drugs, repurposing of approved drugs or in clinical development is likely the only solution. Replication of coronaviruses...
Na minha lista:
| Publicado no: | Front Pharmacol |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7751758/ https://ncbi.nlm.nih.gov/pubmed/33364957 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.582310 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|